Showing 851-860 of 2672 results for "".
Making the Case for Probiotics in Psoriasis Care
https://practicaldermatology.com/topics/psoriasis/making-the-case-for-probiotics-in-psoriasis-care/23702/A literature review reveals much promise, little peril.Can AI and Digital Innovation Improve the Patient Experience?
https://practicaldermatology.com/topics/practice-management/can-ai-and-digital-innovation-improve-the-patient-experience/23964/Embrace AI and how it can help improve points of contact with your patients.Thanks… Was a Memory
https://practicaldermatology.com/series/editors-message/thanks-was-a-memory/23754/5 Ways to Improve the Patient Experience Through Internal Marketing
https://practicaldermatology.com/topics/practice-management/5-ways-to-improve-the-patient-experience-through-internal-marketing/23631/Getting a patient in the door is the first step. Here’s how to build lasting relationships and grow referrals.PBM Restrictions Force Dermatologists to Consider OTC Products
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pbm-restrictions-force-dermatologists-to-consider-otc-products/23578/The latest generation of OTC products for some common dermatologic diseases often feature innovative formulations and clinical studies to show efficacy.Physician Spotlight: Peter van de Kerkhof, MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-peter-van-de-kerkhof-md-phd/23431/Social Distancing and Increased Sun Exposure: A Resource For Patients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/social-distancing-and-increased-sun-exposure-a-resource-for-patients/23391/As patients continue to favor outdoor events, it’s essential they protect their skin.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21171/Cutaneous Manifestations Associated with Nemolizumab
https://practicaldermatology.com/issues/september-2025/cutaneous-manifestations-associated-with-nemolizumab/37628/In the 2025 study by Sasaki et al entitled “Clinical characteristics and risk factors for cutaneous manifestations associated with nemolizumab in atopic dermatitis: a multicenter retrospective study in Japan,” nemolizumab-induced cutaneous eruptions were found to be relatively common, typically occuUpdate on Pediatric Psoriasis
https://practicaldermatology.com/columns/clinical-focus-1/update-on-pediatric-psoriasis/23358/New guidelines and new treatments seek to dramatically improve lives of children with psoriasis.